Table 3.
Baseline | 6-month | p | |
---|---|---|---|
Injected drugs | 40.1 | 27.8 | .000 |
Used previously used needle/syringe a | 22.8 | 9.8 | .027 |
Shared injection equipment a | 26.4 | 18.7 | .138 |
Shared drug solution from other's syringe a | 20.9 | 12.1 | .232 |
Used crack | 59.4 | 45.0 | .000 |
Used rubber tips on crack pipes b | 23.0 | 71.1 | .009 |
Used other non-injection opiates, cocaine or amphetamines | 35.7 | 21.5 | .023 |
Any drug treatment in prior 6 months | 32.7 | 47.7 | .000 |
Had multiple sex partners | 29.0 | 21.1 | .000 |
Had any unprotected sex | 35.3 | 28.3 | .000 |
Unprotected sex with primary partner c | 26.4 | 23.3 | .000 |
Unprotected sex with non-primary partner c | 12.6 | 4.5 | .000 |
Unprotected sex in exchange for money/drugs c | 6.7 | 4.8 | .021 |
Unprotected sex with drug injector c | 6.5 | 4.5 | .000 |
Unprotected sex with crack smoker c | 17.8 | 10.2 | .000 |
Calculated as percent of participants who injected at either baseline or follow-up who completed both surveys (n=92).
Calculated as percent of participants who smoked crack at either baseline or follow-up who completed both surveys (n=152).
Calculated as percent of participants who were sexually active at either baseline or follow-up (n=360).